CPHI vs EMN · rev $4.1M vs P/E 21, rev $9.38B
China Pharma Holdings Inc (CPHI) versus Eastman Chemical Company (EMN) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
CPHI currently screens at market cap $29.0M. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Not investment advice. Open the CPHI and EMN stock pages for the full models.
Not investment advice.